» Articles » PMID: 1598957

Branch Retinal Vein Occlusion and Quadratic Variation in Arteriovenous Crossings

Overview
Journal Am J Ophthalmol
Specialty Ophthalmology
Date 1992 Jun 15
PMID 1598957
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

To explore further the origin and clinically observed regional variation of branch retinal vein occlusion, we studied fluorescein angiograms of 42 patients (42 eyes) with branch retinal vein occlusion and a control population of 126 consecutive patients. In a statistically significant percentage of crossings, the artery was anterior to the vein in those areas of the retina clinically predisposed to branch retinal vein occlusion. Thirty-nine of the 42 patients with branch retinal vein occlusion sites had artery-anterior-to-vein crossings (P = .002), whereas 183 of all 266 arteriovenous crossings in these same eyes were similarly positioned. The artery lay anterior to the vein in significantly more temporal retinal crossings (337 of 457) than nasal retinal crossings (89 of 149; P = .002). Similarly, significantly more superotemporal quadrant crossings (164 of 209) than inferotemporal quadrant crossings (173 of 248) had the artery anterior to the vein (P = .0045). These results suggested that variation in the pattern of arteriovenous crossings may have a role in the clinical distribution of branch retinal vein occlusion.

Citing Articles

Molecular and Cellular Mechanisms Involved in the Pathophysiology of Retinal Vascular Disease-Interplay Between Inflammation and Oxidative Stress.

Srejovic J, Muric M, Jakovljevic V, Srejovic I, Sreckovic S, Petrovic N Int J Mol Sci. 2024; 25(21).

PMID: 39519401 PMC: 11546760. DOI: 10.3390/ijms252111850.


Eph-ephrin signaling couples endothelial cell sorting and arterial specification.

Stewen J, Kruse K, Godoi-Filip A, Zenia , Jeong H, Adams S Nat Commun. 2024; 15(1):2539.

PMID: 38570531 PMC: 10991410. DOI: 10.1038/s41467-024-46300-0.


Efficacy and effectiveness of anti-VEGF or steroids monotherapy versus combination treatment for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.

Zhang W, Liu Y, Sang A BMC Ophthalmol. 2022; 22(1):472.

PMID: 36474156 PMC: 9727869. DOI: 10.1186/s12886-022-02682-7.


Comparison of Ranibizumab Treatment Response of Superior and Inferior Temporal Branch Retinal Vein Occlusion: A Year Follow-Up.

Turkseven Kumral E, Yenerel N, Ercalik N, Karabas L Beyoglu Eye J. 2022; 7(3):207-212.

PMID: 36185983 PMC: 9522989. DOI: 10.14744/bej.2022.46794.


Characteristics of major and macular branch retinal vein occlusion.

Choi Y, Jee D, Kwon J Sci Rep. 2022; 12(1):14103.

PMID: 35982117 PMC: 9388567. DOI: 10.1038/s41598-022-18414-2.